384 related articles for article (PubMed ID: 33338400)
1. RBM-MHC: A Semi-Supervised Machine-Learning Method for Sample-Specific Prediction of Antigen Presentation by HLA-I Alleles.
Bravi B; Tubiana J; Cocco S; Monasson R; Mora T; Walczak AM
Cell Syst; 2021 Feb; 12(2):195-202.e9. PubMed ID: 33338400
[TBL] [Abstract][Full Text] [Related]
2. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
Zhao W; Sher X
PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
[TBL] [Abstract][Full Text] [Related]
3. Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
Pyke RM; Mellacheruvu D; Dea S; Abbott C; Zhang SV; Phillips NA; Harris J; Bartha G; Desai S; McClory R; West J; Snyder MP; Chen R; Boyle SM
Mol Cell Proteomics; 2023 Apr; 22(4):100506. PubMed ID: 36796642
[TBL] [Abstract][Full Text] [Related]
4. Improving the prediction of HLA class I-binding peptides using a supertype-based method.
Wang S; Bai Z; Han J; Tian Y; Shang X; Wang L; Li J; Wu Y
J Immunol Methods; 2014 Mar; 405():109-20. PubMed ID: 24508661
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
Moura RR; Agrelli A; Santos-Silva CA; Silva N; Assunção BR; Brandão L; Benko-Iseppon AM; Crovella S
J Clin Pathol; 2021 Aug; 74(8):528-532. PubMed ID: 32759312
[TBL] [Abstract][Full Text] [Related]
6. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods.
Zhang H; Lundegaard C; Nielsen M
Bioinformatics; 2009 Jan; 25(1):83-9. PubMed ID: 18996943
[TBL] [Abstract][Full Text] [Related]
7. NNAlign_MA; MHC Peptidome Deconvolution for Accurate MHC Binding Motif Characterization and Improved T-cell Epitope Predictions.
Alvarez B; Reynisson B; Barra C; Buus S; Ternette N; Connelley T; Andreatta M; Nielsen M
Mol Cell Proteomics; 2019 Dec; 18(12):2459-2477. PubMed ID: 31578220
[TBL] [Abstract][Full Text] [Related]
8. Deep convolutional neural networks for pan-specific peptide-MHC class I binding prediction.
Han Y; Kim D
BMC Bioinformatics; 2017 Dec; 18(1):585. PubMed ID: 29281985
[TBL] [Abstract][Full Text] [Related]
9. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
10. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.
Abelin JG; Harjanto D; Malloy M; Suri P; Colson T; Goulding SP; Creech AL; Serrano LR; Nasir G; Nasrullah Y; McGann CD; Velez D; Ting YS; Poran A; Rothenberg DA; Chhangawala S; Rubinsteyn A; Hammerbacher J; Gaynor RB; Fritsch EF; Greshock J; Oslund RC; Barthelme D; Addona TA; Arieta CM; Rooney MS
Immunity; 2019 Oct; 51(4):766-779.e17. PubMed ID: 31495665
[TBL] [Abstract][Full Text] [Related]
11. Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction.
Abelin JG; Keskin DB; Sarkizova S; Hartigan CR; Zhang W; Sidney J; Stevens J; Lane W; Zhang GL; Eisenhaure TM; Clauser KR; Hacohen N; Rooney MS; Carr SA; Wu CJ
Immunity; 2017 Feb; 46(2):315-326. PubMed ID: 28228285
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of 174 COVID-19 vaccine candidate epitopes reveals low performance of common epitope prediction tools.
Prachar M; Justesen S; Steen-Jensen DB; Thorgrimsen S; Jurgons E; Winther O; Bagger FO
Sci Rep; 2020 Nov; 10(1):20465. PubMed ID: 33235258
[TBL] [Abstract][Full Text] [Related]
13. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
14. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Papassavas AC; Barnardo MC; Bunce M; Welsh KI
Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
[TBL] [Abstract][Full Text] [Related]
15. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
Mitić NS; Pavlović MD; Jandrlić DR
J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
[TBL] [Abstract][Full Text] [Related]
16. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
17. 'Hotspots' of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization.
Müller M; Gfeller D; Coukos G; Bassani-Sternberg M
Front Immunol; 2017; 8():1367. PubMed ID: 29104575
[TBL] [Abstract][Full Text] [Related]
18. NetMHCpan, a method for MHC class I binding prediction beyond humans.
Hoof I; Peters B; Sidney J; Pedersen LE; Sette A; Lund O; Buus S; Nielsen M
Immunogenetics; 2009 Jan; 61(1):1-13. PubMed ID: 19002680
[TBL] [Abstract][Full Text] [Related]
19. MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing.
O'Donnell TJ; Rubinsteyn A; Laserson U
Cell Syst; 2020 Jul; 11(1):42-48.e7. PubMed ID: 32711842
[TBL] [Abstract][Full Text] [Related]
20. MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties.
Cui J; Han LY; Lin HH; Tang ZQ; Jiang L; Cao ZW; Chen YZ
Immunogenetics; 2006 Aug; 58(8):607-13. PubMed ID: 16832638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
